Cargando…
Characterising differential antibody response is integral to future SARS-CoV-2 serostudies
Autores principales: | Pallett, Scott John Charles, Jones, Rachael, Pallett, Mitchell Anthony, Rayment, Michael, Mughal, Nabeela, Davies, Gary William, Moore, Luke Stephen Prockter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd on behalf of The British Infection Association.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392850/ https://www.ncbi.nlm.nih.gov/pubmed/32739486 http://dx.doi.org/10.1016/j.jinf.2020.07.029 |
Ejemplares similares
-
Early identification of high-risk individuals for monoclonal antibody therapy and prophylaxis is feasible by SARS-CoV-2 anti-spike antibody specific lateral flow assay
por: Pallett, Scott J.C., et al.
Publicado: (2022) -
Healthcare worker perceptions of routine asymptomatic SARS-CoV-2 screening using lateral flow assays: A qualitative analysis across two London hospitals.
por: Heskin, Joseph, et al.
Publicado: (2021) -
Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management
por: Heskin, Joseph, et al.
Publicado: (2022) -
Optimising the initial investigation of suspected cases of SARS-CoV-2 reinfection
por: Pallett, Scott JC., et al.
Publicado: (2021) -
Serological assays for delayed SARS-CoV-2 case identification – Author's reply
por: Pallett, Scott J C, et al.
Publicado: (2020)